SQI Diagnostics Inc. announced that New York State Department of Health (NYSDOH) has given conditional approval to its diagnostic testing partner, KSL Diagnostics Inc. in Buffalo NY, for the EXACT COVID-19 Antibody Test. NYSDOH, under the Clinical Laboratory Evaluation Program, evaluates and authorizes lab-developed tests for use in New York State certified clinical laboratories, which are subject to requirements equal to or more stringent than the Clinical Laboratory Improvement Amendments of 1988 (CLIA). "KSL is proud to partner with SQI in delivering this test and is licensed to test specimens from anywhere in the United States," says Kevin Lawson, President and CEO of KSL.

Access to the EXACT COVID-19 Antibody Test will now be available to physicians and their patients in the United States through AZOVA Inc, a telemedicine testing company that makes healthcare accessible and affordable to Americans through innovative solutions. The EXACT COVID-19 Antibody Test is an advanced COVID-19 antibody test that provides semi-quantitative measurements of six distinct antibodies produced by the immune system in response to exposure to the SARS CoV-2 virus or to COVID-19 vaccination. The small volume blood sample can be collected in a home or office setting with a fingerstick.

A positive test result could indicate the presence of antibodies arising from a prior COVID-19 infection or COVID-19 vaccination.